Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.

about

Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q47282416

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@en

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@nl

type

Item

label

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@en

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@nl

prefLabel

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@en

Plasmatic carbonic anhydrase I ...... ear cell renal cell carcinoma.

@nl

P1476

Plasmatic carbonic anhydrase I ...... lear cell renal cell carcinoma

@en

P2093

Alessio Innocenti

http://www.w3.org/2001/XMLSchema#string

Alfonso Crisci

http://www.w3.org/2001/XMLSchema#string

Claudiu T Supuran

http://www.w3.org/2001/XMLSchema#string

Emanuela Masini

http://www.w3.org/2001/XMLSchema#string

Fabio Cianchi

http://www.w3.org/2001/XMLSchema#string

Laura Lucarini

http://www.w3.org/2001/XMLSchema#string

Laura Papucci

http://www.w3.org/2001/XMLSchema#string

Luca Puccetti

http://www.w3.org/2001/XMLSchema#string

Lucia Magnelli

http://www.w3.org/2001/XMLSchema#string

Nicola Schiavone

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

Cancer statistics, 2010

Biochemical characteristics of caspases-3, -6, -7, and -8

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Why do cancers have high aerobic glycolysis?

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.

Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response.

P304

234-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2017.1411350

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sara Peri

P577

2018-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29251173

http://www.w3.org/2001/XMLSchema#string

P932

7011953

http://www.w3.org/2001/XMLSchema#string